drugset / Trial / NCT00468910
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase II trial is studying how well aspirin works in preventing colorectal cancer in patients at increased risk of colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of aspirin may prevent colorectal cancer.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-12
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | Oral |